Medical News: Panel Endorses Weight-Loss Drug - in Primary Care, Obesity from MedPage Today

Links shared publicly online about this topic.

  • 671
    total visits

Medical News: Panel Endorses Weight-Loss Drug - in Primary Care, Obesity from MedPage Today

medpagetoday.com

SILVER SPRING, Md. -- An FDA advisory committee has voted 13-7 that the modest weight-loss benefits of an investigational combination of naltrexone and bupropion (Contrave) outweigh the drug's blood p

View full resource at medpagetoday.com

Tags: Obesity, Antidepressant, Drug, Smoking Cessation Medication, FDA, Wellbutrin, News

  • Share

Most Recently Shared on December 7, 2010 at 11:46 pm By:

Medical News: Year in Review: Panel Endorses Weight-Loss Drug - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “Our Year in Review series highlights the major medical news stories of 2010. The quest to get new weight-loss drugs to the market was one of the compelling topics that made headlines during the year aView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 26, 2010 at 6:19 pm By:

MedicalNews Medical News Health News

Year in Review: Panel Endorses Weight-Loss Drug http://bit.ly/eHfCNt

1 year ago...

Medical News: New Diet Drug 'Much Needed' in Fight Against Fat - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “WASHINGTON -- In its endorsement of a new weight-loss drug this week, an FDA advisory panel put the wheels in motion to give doctors another option in their never-ending battle to help obese patientsView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2010 at 5:22 pm By:

medpagetoday MedPage Today Health News

New diet drug 'much needed' in fight against fat: http://bit.ly/eAKK18

1 year ago...

Medical News: New Diet Drug 'Much Needed' in Fight Against Fat - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “WASHINGTON -- In its endorsement of a new weight-loss drug this week, an FDA advisory panel put the wheels in motion to give doctors another option in their never-ending battle to help obese patientsView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2010 at 5:12 pm By:

MedicalNews Medical News Health News

New Diet Drug 'Much Needed' in Fight Against Fat http://bit.ly/eXi9Sf

1 year ago...

Medical News: New Diet Drug 'Much Needed' in Fight Against Fat - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “WASHINGTON -- In its endorsement of a new weight-loss drug this week, an FDA advisory panel put the wheels in motion to give doctors another option in their never-ending battle to help obese patientsView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on December 9, 2010 at 5:07 pm By:

medical_tweets medical_tweets Health News

New Diet Drug 'Much Needed' in Fight Against Fat WASHINGTON (MedPage Today) -- In its endorsement of a new weight-loss .. http://dld.bz/Ad98

1 year ago...

Medical News: FDA Panel Turns Thumbs Down on Weight-Loss Drug - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “ADELPHI, Md. -- An FDA advisory committee has voted 9-5 not to recommend lorcaserin hydrochloride (Lorqess), a new weight-loss drug.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 17, 2010 at 1:25 am By:

MedicalNews Medical News Health News

FDA Panel Turns Thumbs Down on Weight-Loss Drug http://ow.ly/192xWU

2 years ago...

Medical News: FDA Panel Mulls Novel Diet Drug - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “ADELPHI, Md. -- Lorcaserin hydrochloride (Lorqess) -- a weight-loss drug aimed at patients with a body mass index of 30 or more -- will be the subject of an FDA advisory committee hearing here on ThurView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 16, 2010 at 1:24 am By:

Medical News: Federal Panel Split Over Fate of Diet Drug - in Primary Care, Obesity from MedPage Today

medpagetoday.com — “ADELPHI, Md. -- An FDA advisory panel handed down a split decision -- 8 to 8 -- after considering on Wednesday whether the weight loss drug sibutramine (Meridia) should be pulled from the market.View full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on September 15, 2010 at 9:34 pm By:

PhysicianAssist Physician Assistants Health News Feed

Federal Panel Split Over Fate of Diet Drug: http://bit.ly/cHAGMZ Can't decide about Meridia and CV side effects

2 years ago...

Advertisement